STAT3 and cancer: A systematic study of naphthoquinone derivatives with inhibitory activity against Stat3 signaling in cancer stem cells disclosed a novel class of furanonaphthoquinone molecules with inhibitory activity against cancer stem cell proliferation (Jiang et al., 2014).